Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen Receives $2.4M from French Investment Firm

NEW YORK (GenomeWeb News) – Molecular diagnostics firm IntegraGen said on Thursday it has received €2 million ($2.4 million) in financing from funds managed by French private investment firm A Plus Finance.

The funds will go toward the continued development of genetic tests for colorectal cancer and liver cancer, Integragen, also based in France, said, and to accelerate R&D and commercialization efforts directed at molecular diagnostics for autism.

IntegraGen was founded in 2000 and specializes in identifying genetic biomarkers for the development of molecular diagnostics with a focus on autism and oncology. In April, the company launched its Arisk Risk Assessment Test, a genetic screening tool for autism.

Its US affiliate, IntegraGen Inc., is based in Cambridge, Mass.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.